View in EDS HTML Full Text PDF Full Text

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.

Saved in:
Bibliographic Details
Title: A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Authors: Feagan BG; The John P Robarts Research Institute, University of Western Ontario, London, ON, Canada. bfeagan@robarts.ca, Sandborn WJ, Baker JP, Cominelli F, Sutherland LR, Elson CO, Salzberg BA, Archambault A, Bernstein CN, Lichtenstein GR, Heath PK, Cameron S, Hanauer SB
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2005 Feb 15; Vol. 21 (4), pp. 373-84.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Print ISSN: 0269-2813 (Print) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 15709987
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Feagan+BG%22">Feagan BG</searchLink>; The John P Robarts Research Institute, University of Western Ontario, London, ON, Canada. bfeagan@robarts.ca<br /><searchLink fieldCode="AU" term="%22Sandborn+WJ%22">Sandborn WJ</searchLink><br /><searchLink fieldCode="AU" term="%22Baker+JP%22">Baker JP</searchLink><br /><searchLink fieldCode="AU" term="%22Cominelli+F%22">Cominelli F</searchLink><br /><searchLink fieldCode="AU" term="%22Sutherland+LR%22">Sutherland LR</searchLink><br /><searchLink fieldCode="AU" term="%22Elson+CO%22">Elson CO</searchLink><br /><searchLink fieldCode="AU" term="%22Salzberg+BA%22">Salzberg BA</searchLink><br /><searchLink fieldCode="AU" term="%22Archambault+A%22">Archambault A</searchLink><br /><searchLink fieldCode="AU" term="%22Bernstein+CN%22">Bernstein CN</searchLink><br /><searchLink fieldCode="AU" term="%22Lichtenstein+GR%22">Lichtenstein GR</searchLink><br /><searchLink fieldCode="AU" term="%22Heath+PK%22">Heath PK</searchLink><br /><searchLink fieldCode="AU" term="%22Cameron+S%22">Cameron S</searchLink><br /><searchLink fieldCode="AU" term="%22Hanauer+SB%22">Hanauer SB</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228707234%22">Alimentary pharmacology & therapeutics</searchLink> [Aliment Pharmacol Ther] 2005 Feb 15; Vol. 21 (4), pp. 373-84.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8707234 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0269-2813 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202692813%22">02692813 </searchLink><i>NLM ISO Abbreviation: </i>Aliment Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15709987
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/j.1365-2036.2005.02336.x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 373
    Titles:
      – TitleFull: A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feagan BG
      – PersonEntity:
          Name:
            NameFull: Sandborn WJ
      – PersonEntity:
          Name:
            NameFull: Baker JP
      – PersonEntity:
          Name:
            NameFull: Cominelli F
      – PersonEntity:
          Name:
            NameFull: Sutherland LR
      – PersonEntity:
          Name:
            NameFull: Elson CO
      – PersonEntity:
          Name:
            NameFull: Salzberg BA
      – PersonEntity:
          Name:
            NameFull: Archambault A
      – PersonEntity:
          Name:
            NameFull: Bernstein CN
      – PersonEntity:
          Name:
            NameFull: Lichtenstein GR
      – PersonEntity:
          Name:
            NameFull: Heath PK
      – PersonEntity:
          Name:
            NameFull: Cameron S
      – PersonEntity:
          Name:
            NameFull: Hanauer SB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 02
              Text: 2005 Feb 15
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 0269-2813
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Alimentary pharmacology & therapeutics
              Type: main
ResultId 1